Yeddyurappa hosts lunch to 102 Dalits at his house, gifts them sarees, dhoties

Mangaluru, Jun 12: A huge crowd gathered for the grand opening of the newly built 175-metre-long two-lane bridge across Phalguni River on National Highway 169 near Gurupura on the outskirts of the city today.

Even as the photos of the bridge inauguration ceremony went viral on social media, netizens took the elected representatives and the district administration to task for flouting safety norms at a time when the coronavirus cases are continuing to mount in coastal Karnataka.

The bridge was completed in a record time of 15 months. Dakshina Kannada MP and State BJP President Nalin Kumar Kateel and district in-charge Minister Kota Srinivas Poojari inaugurated the bridge in the presence of Mangaluru City North MLA Y. Bharath Shetty and others.

The bridge has come as a breather to thousands of travellers between Mangaluru-Moodbidri-Karkala on the busy NH. The age-old steel bridge had become dilapidated and was a cause for concern for road users. The highway is also under the process of getting widened to four lanes.

The bridge was constructed at an estimated cost of Rs 30 crore by contractor Sudhakar Shetty of Mugrodi Construction. Work started in February last and the contractor had time till February next.

While the two-lane carriageway is 16 metres wide, the bridge has 2.5-metre-wide pedestrian paths on both the sides. New approach roads of 500 metres each were also part of the project.

 Mangaluru, July 18: The coastal districts of Dakshina Kannada and Udupi recorded a total of 346 covid positive cases in last 24 hours. Dakshina Kannada recorded 4 new deaths.

While DK recorded 237 positive cases, neighbouring Udupi saw 109 people testing positive. It may be recalled that DK and Udupi had reported a combined record spurt of 347 Covid-19 cases for a single day on Thursday. 

Dakshina Kannada 

As many as 26,368 samples have been sent for tests so far. Among them 23,096 have turned out negative, and 3,311 people have received positive report. Currently there are 1,848 active cases while 1,387 persons have recovered. 109 patients were discharged from Wenlock as well as private hospitals today. Including today’s four deaths, 75 people have succumbed to covid. Among them 12 are from other districts.

The patients whose deaths were reported today are a 74-year-old female from Puttur who was also suffering from heart disease and asthma, a 67-year-old male who was suffering from pneumonia and was on ventilator, and two females aged 49 and 61 from Mangaluru who suffered cardiac arrest.

Udupi

With 109 new cases, the total number of covid positive cases reported in the district mounted to 2088. Among new cases 58 belong to Udupi taluk, 40 are from Kundapur and 11 from Karkala. 

A total of 24,382 samples have been collected so far, including 524 on Saturday, out of which 17 are coronavirus suspects and 317 are COVID contacts. Out of them, 21,757 samples have turned out to be negative, including 292 on Saturday, and 537 reports are awaited.

As many as 1,586 patients have been discharged so far including 43 on Saturday, and 492 cases are currently active. Ten deaths have occurred so far. One positive case has been transferred to Dakshina Kannada.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.